1. Home
  2. SY vs AVIR Comparison

SY vs AVIR Comparison

Compare SY & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo So-Young International Inc. American Depository Shares

SY

So-Young International Inc. American Depository Shares

HOLD

Current Price

$2.63

Market Cap

289.0M

Sector

Technology

ML Signal

HOLD

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

HOLD

Current Price

$3.45

Market Cap

266.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SY
AVIR
Founded
2013
2012
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
289.0M
266.4M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
SY
AVIR
Price
$2.63
$3.45
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$5.50
$6.00
AVG Volume (30 Days)
552.0K
399.2K
Earning Date
11-17-2025
11-12-2025
Dividend Yield
1.00%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$201,132,009.00
N/A
Revenue This Year
$6.36
N/A
Revenue Next Year
$57.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.67
$2.46
52 Week High
$6.28
$4.02

Technical Indicators

Market Signals
Indicator
SY
AVIR
Relative Strength Index (RSI) 41.57 54.53
Support Level $2.46 $3.34
Resistance Level $3.00 $3.63
Average True Range (ATR) 0.15 0.16
MACD 0.01 -0.00
Stochastic Oscillator 34.55 56.91

Price Performance

Historical Comparison
SY
AVIR

About SY So-Young International Inc. American Depository Shares

So-Young International Inc is an online destination for discovering, evaluating, and reserving medical aesthetic services in China. Its business model comprises four integrated components: professional content and its distribution through social media networks and its targeted media platforms in China, a social community characterized by signature user-generated content, Online reservation services for a medical aesthetic treatment, and the research, development, production, sales and agency of laser and other optoelectronic medical beauty equipment. It generates revenue from information services fees and reservation services fees from medical aesthetic service providers.

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).

Share on Social Networks: